Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones, Mark Agulnik, Gregory M. Coté, Víctor M. Villalobos, Steven Attia, Rashmi Chugh, Tom Wei‐Wu Chen, Thierry Jahan, Elizabeth T. Loggers, Abha A. Gupta, Antoîne Italiano, George D. Demetri, Ravin Ratan, Lara E. Davis, Olivier Mir, Palma Dileo, Brian A. Van Tine, Joseph G. Pressey, Trupti Lingaraj, Anand Rajarethinam, Laura Sierra, Shefali Agarwal, Silvia Stacchiotti
Topics & Concepts
Epithelioid sarcomaSMARCB1MedicineSarcomaDermatologyOncologyInternal medicinePathologyChemistryGeneChromatinBiochemistryChromatin remodelingChromatin Remodeling and CancerNeurofibromatosis and Schwannoma CasesMechanisms of cancer metastasis